BSECompany UpdateRating Change26 Aug 2026
Resonance Specialties Ltd-$
Disclosure in terms of Regulation 30 of SEBI (LODR), 2015 regarding ratings assigned by CRISIL
Resonance Specialties Ltd has announced that CRISIL has reaffirmed its credit ratings for various financial facilities of the company, with a long-term rating of CRISIL BBB-/Stable.
BSECompany Update19 Aug 2026
Resonance Specialties Ltd-$
Newspaper Notice in respect of Postal Ballot Notice / E-voting details of Postal Ballot
Resonance Specialties Ltd has completed the electronic dispatch of the postal ballot notice and e-voting details for the 17th Annual General Meeting (AGM) to be held on September 9, 2026. The notice is available on the company's website and the website of National Securities Depository Limited (NSDL). The e-voting period commences from August 20, 2026, and the AGM will be held through Video Conferencing (VC) or Other Audio Visual Means (OAVM).
BSEAGM/EGMRelated Party17 Aug 2026
Resonance Specialties Ltd-$
Postal Ballot Notice for seeking approval of Members of the Company for Material Related Party Transaction with Kaygee Laboratories Private Limited
Resonance Specialties Ltd has announced a postal ballot notice seeking approval from members for a material related party transaction with Kaygee Laboratories Private Limited for the purchase of KLPL's manufacturing facility for Rs. 29.98 crores on slump sale basis.
BSECompany UpdateResults5 Aug 2026
Resonance Specialties Ltd-$
NEWSPAPER RESULTS 30.06.2026
Resonance Specialties Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a total income from operations of ₹3,258.41 lakhs and a net profit of ₹574.42 lakhs.
BSEAGM/EGMResults5 Aug 2026
Resonance Specialties Ltd-$
Voting Results of 37th AGM held on 04.08.2026 along with Scrutinizer''s Report.
Resonance Specialties Ltd. held its 37th Annual General Meeting on August 4, 2026, where all six proposed resolutions were passed by a requisite majority. The meeting was attended by 2 promoters and 58 public shareholders through video conferencing. The resolutions included the appointment of a director, declaration of dividend, re-appointment of statutory auditors, and approval of related party transactions.
BSEAGM/EGMResults4 Aug 2026
Resonance Specialties Ltd-$
Proceedings of 37th AGM held on 04.08.2026
Resonance Specialties Ltd held its 37th Annual General Meeting on August 4, 2026, through video conferencing. The meeting approved various items, including the audited financial statements, director reappointment, dividend declaration, and related party transactions.
BSECompany UpdateRelated Party4 Aug 2026
Resonance Specialties Ltd-$
PURCHASE OF MANUFACTURING UNIT FROM KAYGEE LABORATORIES PVT LTD
Resonance Specialties Ltd has approved the purchase of a manufacturing unit from Kaygee Laboratories Private Limited, a related party, for Rs. 29.98 crores. The manufacturing unit is situated at Mandideep, Madhya Pradesh, and is engaged in the development, manufacturing, and distribution of specialty chemicals and APIs.
BSEResultResults4 Aug 2026
Resonance Specialties Ltd-$
UNAUDITED FINANCIAL RESULTS FOR Q1 FY27
Resonance Specialties Ltd has announced unaudited Q1 FY27 results and the purchase of a manufacturing facility from a related party, Kaygee Laboratories Private Limited, for Rs. 29.98 crores.
BSEBoard MeetingRelated Party4 Aug 2026
Resonance Specialties Ltd-$
OUTCOME OF BOARD MEETING 04.08.2026
Resonance Specialties Ltd. has approved the purchase of a manufacturing facility from a related party, Kaygee Laboratories Private Limited, for Rs. 29.98 crores. The facility is situated at Mandideep, Madhya Pradesh, and will be acquired on a slump sale basis, subject to shareholder approval.
BSEBoard MeetingResults23 Jul 2026
Resonance Specialties Ltd-$
Resonance Specialties Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the unaudited financial ....
Resonance Specialties Ltd has informed BSE that the meeting of the Board of Directors is scheduled on August 4, 2026, to consider and approve the unaudited financial results for the 1st quarter ended June 30, 2026.